Results 131 to 140 of about 8,988 (194)

HER2-positive neuroendocrine breast carcinoma: a case study uncovers <i>CCND1</i>, <i>FGF19</i>, and <i>IGF1R</i> amplifications as new molecular drivers. [PDF]

open access: yesPathologica
Zordan M   +12 more
europepmc   +1 more source

Is Minimal Change Disease Associated with Prostate Cancer or Is Age Just a Number? [PDF]

open access: yesReports (MDPI)
Kleinová P   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

LHRH-receptors and LHRH-agonist treatment in ovarian cancer: An overview

The Journal of Steroid Biochemistry and Molecular Biology, 1990
Considerable evidence exists that ovarian cancer might be gonadotrophin-dependent. Receptors for LH and FSH have been discovered in these tumors. Proliferation of ovarian cancer cells in vitro could be stimulated by gonadotrophins. Withdrawal of LH and FSH in animal models of ovarian cancer inhibited growth of these tumors.
G, Emons   +5 more
openaire   +3 more sources

Glucocorticoid Receptors in LHRH Neurons

Neuroendocrinology, 1992
Luteinizing hormone-releasing hormone (LHRH)-producing neurons constitute the final pathway for regulation of reproductive endocrine function by the central nervous system. Chronically elevated levels of glucocorticoids exert an inhibitory effect on reproductive function.
R S, Ahima, R E, Harlan
openaire   +2 more sources

Home - About - Disclaimer - Privacy